Mapping technique to reassess Alzheimer's studies finds improved reproducibility

December 14, 2018

A neural mapping approach that pegs results from more than two dozen previous Alzheimer's studies found that reproducibility improves when trying to isolate symptoms to a brain network rather than a single area of the brain.

This is the first study to use "meta analysis network mapping" to essentially show results from prior studies that can't be reproduced to a single location in the brain are mappable to a distributed network, said Ryan Darby, MD an assistant professor of neurology at Vanderbilt University Medical Center, who is first author of the paper that will run in Brain in January.

"The study changes the assumption for where symptoms or cognitive processes should localize - away from a specific region and toward localizing to a brain network. Changing that assumption improves reproducibility," said Darby.

Neural networks include regions in different parts of the brain that are connected together (akin to distant cities connected by highways), so the study zoomed out its examination to think about symptom-specific circuitry rather than a single spot.

Of the 26 Alzheimer's studies examined, reproducibility to a specific region came to 20 to 30 percent - a low rate that highlights one of the persistent challenges in studies. But when looking at reproducibility to a network, the rate surged to 100 percent.

Darby called the results powerful.

The inquiry started with Alzheimer's disease and dementia because the theory in those disorders suggests it spreads across connected brain networks.

The study also found that studies of Alzheimer's disease patients with delusions localized to the same brain network that Darby found associated with brain lesions causing delusions. In the future he wants these findings and method to shed light on a path to therapy by identifying the symptom-specific brain network.

"We're hoping to look at individual patients with dementia and then eventually individual psychiatric patients. What we hope to see is that there actually is a consistent localization for the same symptom across different diseases, which is hard because different diseases disrupt brain function in different ways- but if we unite things at a network level then we can ask, 'is this the common way to understand this symptom across different diseases?' That's what I hope," said Darby.
-end-


Vanderbilt University Medical Center

Related Dementia Articles from Brightsurf:

The danger of Z-drugs for dementia patients
Strong sleeping pills known as 'Z-drugs' are linked with an increased risk of falls, fractures and stroke among people with dementia, according to new research.

The long road to dementia
Alzheimer's disease develops over decades. It begins with a fatal chain reaction in which masses of misfolded beta-amyloid proteins are produced that in the end literally flood the brain.

Why people with dementia go missing
People with dementia are more likely to go missing in areas where road networks are dense, complicated and disordered - according to new research from the University of East Anglia.

PTSD may double risk of dementia
People who have experienced post-traumatic stress disorder (PTSD) are up to twice as likely to develop dementia later in life, according to a new study by UCL researchers, published in the British Journal of Psychiatry.

Dementia education
School-based dementia education could deliver much needed empathy and understanding for older generations as new research from the University of South Australia shows it can significantly improve dementia knowledge and awareness among younger generations.

Building dementia friendly churches
A project to help church communities become more 'dementia friendly' has had a significant impact across the country.

A "feeling" for dementia?
A research team led by the DZNE concludes that personal perception can be an important indicator for the early detection of Alzheimer's disease.

New biomarker for dementia diagnosis
Medical researchers in the UK and Australia have identified a new marker which could support the search for novel preventative and therapeutic treatments for dementia.

Digital solutions for dementia care
Telehealth delivery of dementia care in the home can be as effective as face-to-face home visit services if carers and recipients take advantage of the technologies available, Australian researchers say.

Despite a marked reduction in the prevalence of dementia, the number of people with dementia is set to double by 2050 according to new Alzheimer Europe report
Today, at a European Parliament lunch debate, Alzheimer Europe launched a new report presenting the findings of its collaborative analysis of recent prevalence studies and setting out updated prevalence rates for dementia in Europe.

Read More: Dementia News and Dementia Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.